Skip to main content
CriticalFDAfda-F-1535-2024CHEMICAL EXPOSURE

Diamond Shruumz Gummies - Micro Dose Sour Peach Apple UPC 755003861386

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (chemical exposure). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
248,007
Recall Date
June 27, 2024
Issuing Agency
Hazard
Chemical Exposure

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1535-2024.

Toxic levels of muscimol

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1535-2024.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Prophet Premium Blends, Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1535-2024.

Prophet Premium Blends, LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Prophet Premium Blends, Llc Recall FAQ

Prophet Premium Blends, Llc is the subject of a food safety report: Diamond Shruumz Gummies - Micro Dose Sour Peach Apple UPC 755003861386. The notice was published on June 27, 2024 by the U.S. Food and Drug Administration (FDA). Approximately 248,007 units are potentially affected.